ScholarIQanswers from OpenAlex

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor

PaperCitations, authors & open-access status

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor have?

ScholarIQcitation count

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor has 219 citations in the OpenAlex counts ScholarIQ stores.

When was Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor published?

ScholarIQyear

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor has 2000 year in the ScholarIQ index.

What is the open-access status of Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor?

ScholarIQoa status

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor has bronze oa status in the ScholarIQ index.

What is the DOI of Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor?

ScholarIQdoi

The DOI for Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor is on the source record.

What is the PMID of Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor?

ScholarIQpmid

The PMID for Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor is on the source record.

What is the OpenAlex record for Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor?

ScholarIQopenalex

The OpenAlex for Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial